News
Highly sensitive detection methods allow ever deeper insights into complex chemical processes in the atmosphere: Researchers ...
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial Patients ... Fig 1. CONSORT diagram of ...
Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...
5-12 MyPathway is an ongoing, multicenter, phase IIa study that combines multiple basket studies under an adaptable master protocol. The objective of the study is to evaluate the efficacy of ...
Obicetrapib is a highly selective cholesteryl ester transfer protein inhibitor that reduces low-density lipoprotein (LDL) cholesterol levels. The efficacy and safety of obicetrapib have not been ...
UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...
Abstract: We propose and demonstrate a tunable broadband photonic radio frequency (RF) phase shifter based on a silicon microring resonator. This scheme utilizes the thermal nonlinear effect of the ...
Furthermore, the adaptive phase lead (APL) mechanism can improve inherent propagation delay attributable to low-power and non-ideal comparator, thus improving load regulation by a maximum of 30 mV.
SAN DIEGO, April 30, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 3 registrational program to evaluate the efficacy, safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results